清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Predictors of Favorable Outcome after Endovascular Thrombectomy in MRI: Selected Patients with Acute Basilar Artery Occlusion

改良兰金量表 闭塞 冲程(发动机) 放射科 回顾性队列研究 磁共振成像 血管造影 血管内治疗 外科
作者
Mehdi Mahmoudi,Cyril Dargazanli,F. Cagnazzo,I. Derraz,Caroline Arquizan,A. Wacogne,Julien Labreuche,Alain Bonafe,Denis Sablot,Pierre-Henri Lefevre,G. Gascou,Nicolas Gaillard,C. Scott,Vincent Costalat,Isabelle Mourand
出处
期刊:American Journal of Neuroradiology [American Society of Neuroradiology]
卷期号:41 (9): 1670-1676 被引量:6
标识
DOI:10.3174/ajnr.a6741
摘要

BACKGROUND AND PURPOSE: Clinical outcomes after endovascular treatment for acute basilar artery occlusions need further investigation. Our aim was to analyze predictors of a 90-day good functional outcome defined as mRS 0–2 after endovascular treatment in MR imaging–selected patients with acute basilar artery occlusions. MATERIALS AND METHODS: We analyzed consecutive MR imaging–selected patients with acute basilar artery occlusions endovascularly treated within the first 24 hours after symptom onset. Successful and complete reperfusion was defined as modified TICI scores 2b–3 and 3, respectively. Outcome at 90 days was analyzed in univariate and multivariate analysis regarding baseline patient treatment characteristics and periprocedural outcomes. RESULTS: One hundred ten patients were included. In 10 patients, endovascular treatment was aborted for failed proximal/distal access. Overall, successful reperfusion was achieved in 81.8% of cases (n = 90; 95% CI, 73.3%–88.6%). At 90 days, favorable outcome was 31.8%, with a mortality rate of 40.9%; the prevalence of symptomatic intracranial hemorrhage within 24 hours was 2.7%. The median time from symptom onset to groin puncture was 410 minutes (interquartile range, 280–540 minutes). In multivariable analysis, complete reperfusion (OR = 6.59; 95% CI, 2.17–20.03), lower pretreatment NIHSS (OR = 0.77; 95% CI, 0.64–0.94), the presence of posterior communicating artery collateral flow (OR = 2.87; 95% CI, 1.05–7.84), the absence of atrial fibrillation (OR = 0.18; 95% CI, 0.03–0.99), and intravenous thrombolysis administration (OR = 2.75; 95% CI, 1.04–7.04) were associated with 90-day favorable outcome. CONCLUSIONS: In our series of MR imaging–selected patients with acute basilar artery occlusions, complete reperfusion was the strongest predictor of a good outcome. Lower pretreatment NIHSS, the presence of posterior communicating artery collateral flow, the absence of atrial fibrillation, and intravenous thrombolysis administration were associated with favorable outcome.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
非洲大象完成签到,获得积分10
2秒前
nwq完成签到,获得积分10
3秒前
12秒前
14秒前
17秒前
17秒前
17秒前
18秒前
18秒前
19秒前
benbenca发布了新的文献求助10
20秒前
benbenca发布了新的文献求助10
20秒前
22秒前
22秒前
22秒前
22秒前
23秒前
benbenca发布了新的文献求助10
23秒前
benbenca发布了新的文献求助10
23秒前
23秒前
benbenca发布了新的文献求助10
24秒前
24秒前
benbenca发布了新的文献求助10
24秒前
benbenca发布了新的文献求助10
25秒前
benbenca发布了新的文献求助10
25秒前
26秒前
26秒前
benbenca发布了新的文献求助10
27秒前
benbenca发布了新的文献求助10
27秒前
28秒前
28秒前
benbenca发布了新的文献求助10
28秒前
benbenca发布了新的文献求助10
28秒前
benbenca发布了新的文献求助10
28秒前
benbenca发布了新的文献求助10
29秒前
benbenca发布了新的文献求助10
29秒前
benbenca发布了新的文献求助10
30秒前
30秒前
30秒前
31秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Arthritis and Related Conditions, An Issue of Orthopedic Clinics 1000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7290350
求助须知:如何正确求助?哪些是违规求助? 8909561
关于积分的说明 18856915
捐赠科研通 6957895
什么是DOI,文献DOI怎么找? 3209105
关于科研通互助平台的介绍 2378856
邀请新用户注册赠送积分活动 2184883